相关实验视频

Updated: Jan 8, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

[使用免疫疗法治疗肺癌的现代治疗]

Krisztina Bogos¹, Gabriella Temesi¹, Marianna Pucsok¹

¹Országos Korányi Pulmonológiai Intézet, Budapest, Hungary. bogos@koranyi.hu.

Magyar onkologia

|December 12, 2025

概括

包括免疫疗法和化疗在内的全身治疗对于所有阶段的非小细胞肺癌至关重要. 免疫检查点抑制剂在各种环境中表现有前途,包括新辅助,辅助和晚期疾病.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
肺癌研究研究肺癌研究

背景情况:

系统性治疗对于早期,局部晚期和转移性阶段的非小细胞肺癌 (NSCLC) 是至关重要的.
目前对NSCLC的新辅助方法主要涉及免疫疗法与化疗相结合.
免疫检查点抑制剂 (ICI) 在辅助设置中建立,并在外科设置中显示积极的结果.

研究的目的:

审查当前的证据和系统治疗的作用,特别是免疫疗法,在非小细胞肺癌的各个阶段.
突出多学科瘤委员会在NSCLC个性化治疗决策中的重要性.
讨论免疫疗法在晚期NSCLC的应用和小细胞肺癌的进展.

主要方法:

临床试验和基于证据的指导方针的文献综述.
对免疫疗法和化疗组合的数据分析.
评估ICI在NSCLC和SCLC的新辅助,辅助,外科及高级设置中的疗效.

主要成果:

免疫疗法加化疗是NSCLC的关键新辅助方法.
ICI在辅助环境中是有效的,并且在外科手术期间显示出有希望的结果.
免疫疗法对先进的,非基因驱动的NSCLC有很好的定义,并且在小细胞肺癌中取得了进展.

结论:

系统疗法,特别是免疫疗法,在整个NSCLC管理过程中发挥着重要作用.
由多学科瘤委员会指导的个性化治疗决策至关重要.
ICI代表了非小细胞和小细胞肺癌治疗的重大进步.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...